Phase I Oncology Drug Development - Image 1

£80.09

Springer Phase I Oncology Drug Development

Name: Phase I Oncology Drug Development
Brand: Springer
Price: 80.09 GBP
Availability: InStock

Diseases & Disorders

About as cheap as it gets. The only time it was cheaper was 1 year ago.

£80 today · all-time low £78 (Dec 2024) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 638 days • 638 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 638 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £80 (403 days, 63.2%)

Price range: £78 - £90

Price levels: 4 different prices over 638 days

Description

This book provides a detailed review of how oncology drug development has changed over the past decade, and serves as a comprehensive guide for the practicalities in setting up phase I trials. The book covers strategies to accelerate the development of novel antitumor compounds from the laboratory to clinical trials and beyond through the use of innovative mechanism-of-action pharmacodynamic biomarkers and pharmacokinetic studies. The reader will learn about all aspects of modern phase I trial designs, including the incorporation of precision medicine strategies, and approaches for rational patient allocation to novel anticancer therapies. Circulating biomarkers to assess mechanisms of response and resistance are changing the way we are assessing patient selection and are also covered in this book. The development of the different classes of antitumor agents are discussed, including chemotherapy, molecularly targeted agents, immunotherapies and also radiotherapy. Theauthors also discuss the lessons that the oncology field has learnt from the development of hematology-oncology drugs and how such strategies can be carried over into therapies for solid tumors. There is a dedicated chapter that covers the specialized statistical approaches necessary for phase I trial designs, including novel Bayesian strategies for dose escalation. This volume is designed to help clinicians better understand phase I clinical trials, but would also be of use to translational researchers (MDs and PhDs), and drug developers from academia and industry interested in cancer drug development. It could also be of use to phase I trial study coordinators, oncology nurses and advanced practice providers. Other health professionals interested in the treatment of cancer will also find this book of great value.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3030476847
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain: Amazon UK
Release Date: 18 September 2021
Listed Since: 21 August 2021

Barcode

No barcode data available

Springer Phase I Oncology Drug Development

About as cheap as it gets. The only time it was cheaper was 1 year ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Cancer Chemotherapy: Basic Science to the Clinic

CRC Press Statistical Approaches in Oncology Clinical Development

Statistical Approaches in Oncology Clinical Development: Current Paradigm and Methodological Advancement (Chapman & Hall/CRC Biostatistics Series)

Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)

Handbook of Cancer Treatment-Related Symptoms and Toxicities

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Evidence–Based Oncology (Evidence–Based Medicine)

Demos Medical Oncology Clinical Trials Design and Analysis Book

Therapeutic Approaches in Cancer Treatment: 185 (Cancer Treatment and Research, 185)

Chemotherapy Protocols and Infusion Sequence: Schedule Consideration in Cancer Treatment

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Methods and Biostatistics in Oncology: Understanding Clinical Research as an Applied Tool

The Bethesda Handbook of Clinical Oncology

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Novel Designs of Early Phase Trials for Cancer Therapeutics

Textbook of Clinical Trials in Oncology: A Statistical Perspective

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Chemistry and Pharmacology of Anticancer Drugs

Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice

Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics)

Oncology Clinical Trials: Successful Design, Conduct, and Analysis